Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts-Reference-Cited by-同舟云学术

Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts

Published:2019-09 Issue:9 Volume:18 Page:102359
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Ruiz-Irastorza Guillermo,Ruiz-Estevez Beatriz,Lazaro Estibaliz,Ruiz-Arruza Ioana,Duffau Pierre,Martin-Cascon Miguel,Richez Christophe,Ugarte Amaia,Blanco Patrick

Funder

BBK-BIOCRUCES

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Patterns of disease activity in systemic lupus erythematosus;Barr;Arthritis Rheum,1999

2. Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort;Györi;Lupus Sci Med,2017

3. SLE: the changing prognosis;Ugarte;Lupus,2016

4. Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight;Doria;Lupus,2015

5. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinincs (SLICC) inception cohort;Bruce;Ann Rheum Dis,2015

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Predictors of Mood Disorders and Prevalence of Neuropsychiatric Symptoms in Patients with Systemic Lupus Erythematosus;Journal of Clinical Medicine;2024-09-13

2. Modern treatment options for systemic lupus erythematosus in children (literature review);Modern Rheumatology Journal;2024-08-21

3. Lupus Nephritis from Pathogenesis to New Therapies: An Update;International Journal of Molecular Sciences;2024-08-18

4. Intermittent pulses of methylprednisolone with low-dose prednisone attenuate lupus symptoms in B6.MRL-Faslpr/J mice with fewer glucocorticoid side effects;Biomedicine & Pharmacotherapy;2024-08

5. Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark;Lupus;2024-06-20